BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21875956)

  • 1. Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease.
    Vanvalkenburgh J; Albu DI; Bapanpally C; Casanova S; Califano D; Jones DM; Ignatowicz L; Kawamoto S; Fagarasan S; Jenkins NA; Copeland NG; Liu P; Avram D
    J Exp Med; 2011 Sep; 208(10):2069-81. PubMed ID: 21875956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset.
    Kuczma M; Podolsky R; Garge N; Daniely D; Pacholczyk R; Ignatowicz L; Kraj P
    J Immunol; 2009 Sep; 183(6):3731-41. PubMed ID: 19710455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.
    Liu T; Soong L; Liu G; König R; Chopra AK
    Biol Direct; 2009 Oct; 4():40. PubMed ID: 19852824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl11b prevents fatal autoimmunity by promoting T
    Drashansky TT; Helm E; Huo Z; Curkovic N; Kumar P; Luo X; Parthasarathy U; Zuniga A; Cho JJ; Lorentsen KJ; Xu Z; Uddin M; Moshkani S; Zhou L; Avram D
    Sci Adv; 2019 Aug; 5(8):eaaw0480. PubMed ID: 31457080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl11b prevents catastrophic autoimmunity by controlling multiple aspects of a regulatory T cell gene expression program.
    Hasan SN; Sharma A; Ghosh S; Hong SW; Roy-Chowdhuri S; Im SH; Kang K; Rudra D
    Sci Adv; 2019 Aug; 5(8):eaaw0706. PubMed ID: 31457081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis.
    Lo Re S; Lecocq M; Uwambayinema F; Yakoub Y; Delos M; Demoulin JB; Lucas S; Sparwasser T; Renauld JC; Lison D; Huaux F
    Am J Respir Crit Care Med; 2011 Dec; 184(11):1270-81. PubMed ID: 21868503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OX40 is required for regulatory T cell-mediated control of colitis.
    Griseri T; Asquith M; Thompson C; Powrie F
    J Exp Med; 2010 Apr; 207(4):699-709. PubMed ID: 20368580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.
    Maul J; Loddenkemper C; Mundt P; Berg E; Giese T; Stallmach A; Zeitz M; Duchmann R
    Gastroenterology; 2005 Jun; 128(7):1868-78. PubMed ID: 15940622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3
    Chen X; Berin MC; Gillespie VL; Sampson HA; Dunkin D
    Front Immunol; 2021; 12():637630. PubMed ID: 33717186
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.
    Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA
    J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-15-dependent balance between Foxp3 and RORγt expression impacts inflammatory bowel disease.
    Tosiek MJ; Fiette L; El Daker S; Eberl G; Freitas AA
    Nat Commun; 2016 Mar; 7():10888. PubMed ID: 26964669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory cytokine IL-35 contributes to regulatory T-cell function.
    Collison LW; Workman CJ; Kuo TT; Boyd K; Wang Y; Vignali KM; Cross R; Sehy D; Blumberg RS; Vignali DA
    Nature; 2007 Nov; 450(7169):566-9. PubMed ID: 18033300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ets-1 transcription factor controls the development and function of natural regulatory T cells.
    Mouly E; Chemin K; Nguyen HV; Chopin M; Mesnard L; Leite-de-Moraes M; Burlen-defranoux O; Bandeira A; Bories JC
    J Exp Med; 2010 Sep; 207(10):2113-25. PubMed ID: 20855499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.
    Yurchenko E; Levings MK; Piccirillo CA
    Eur J Immunol; 2011 Dec; 41(12):3455-66. PubMed ID: 21956668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.
    Takahashi R; Nishimoto S; Muto G; Sekiya T; Tamiya T; Kimura A; Morita R; Asakawa M; Chinen T; Yoshimura A
    J Exp Med; 2011 Sep; 208(10):2055-67. PubMed ID: 21893603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
    Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
    Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis.
    Murai M; Turovskaya O; Kim G; Madan R; Karp CL; Cheroutre H; Kronenberg M
    Nat Immunol; 2009 Nov; 10(11):1178-84. PubMed ID: 19783988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology.
    Kamanaka M; Huber S; Zenewicz LA; Gagliani N; Rathinam C; O'Connor W; Wan YY; Nakae S; Iwakura Y; Hao L; Flavell RA
    J Exp Med; 2011 May; 208(5):1027-40. PubMed ID: 21518800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.